Risk of Inflammatory Bowel Disease After Anti-CD20 Treatment in Multiple Sclerosis. Kallin S, Svenningsson A, Olén O, Hedin C, Lycke J, Alping P JAMA Neurol. 2026 Oct 22. PMID: 42911175. Abstract CommentRecommendBookmarkWatch
